Sort   by:  
 Page size 
UnknownCefotaxime resistant Escherichia coli collected from a healthy volunteer; characterisation and the effect of plasmid loss.
Not available
S-EPMC3873979 | biostudies-literature
UnknownImpact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson's Disease in Germany (Care4PD).
Not available
S-EPMC8773478 | biostudies-literature
UnknownDevice-Aided Therapies in Parkinson's Disease-Results from the German Care4PD Study.
Not available
S-EPMC10216485 | biostudies-literature
UnknownReduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19.
Not available
S-EPMC9629592 | biostudies-literature
UnknownNeoTRACK trial: <u>Neo</u>adjuvant <u>T</u>i<u>R</u>agolumab, <u>A</u>tezolizumab and <u>C</u>hemotherapy - dissection of IO- efficacy in NSCLC by longitudinal trac<u>K</u>ing - protocol of a non-randomised, open-label, single-arm, phase II study.
Not available
S-EPMC11956294 | biostudies-literature
UnknownDeciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma.
Not available
S-EPMC8783861 | biostudies-literature
UnknownInvestigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial – ICONICplus Trial
Not available
S-EPMC12352239 | biostudies-literature
UnknownDe Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer.
Not available
S-EPMC8063726 | biostudies-literature
UnknownKRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma.
Not available
S-EPMC11300455 | biostudies-literature
UnknownCa2+ and CACNA1H mediate targeted suppression of breast cancer brain metastasis by AM RF EMF.
Not available
S-EPMC6604768 | biostudies-literature
Sort   by:  
 Page size